Large-cap Health Care company BioNTech SE has logged a 2.5% change today on a trading volume of 480,216. The average volume for the stock is 692,062.
BioNTech SE, a biotechnology company, develops and commercializes immunotherapies for cancer and other infectious diseases. Based in Mainz, Germany the company has 5,500 full time employees and a market cap of $26,113,677,312.
The company is now trading -32.43% away from its average analyst target price of $160.36 per share. The 17 analysts following the stock have set target prices ranging from $107.36 to $258.46, and on average give BioNTech SE a rating of buy.
|Date Reported||Total Revenue ($ k)||Net Profit ($ k)||Net Margins (%)||YoY Growth (%)|